Determination of Drug-to-Antibody Distribution in Cysteine-Linked ADCs

Applications | 2017 | Agilent TechnologiesInstrumentation
HPLC
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Antibody-Drug Conjugate (ADC) Analysis with the Agilent ProteoAnalyzer System
Agilent Biocolumns - Critical Quality Attributes - Application Compendium
Characterization of Antibody‑Drug Conjugates Using 2D-LC and Native MS
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
2026|Agilent Technologies|Brochures and specificationsApplications